|
PRRG4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.197130E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.983200E-04 |
| Normal-vs-Stage2 |
7.682000E-02 |
| Normal-vs-Stage3 |
3.614200E-04 |
| Normal-vs-Stage4 |
1.921970E-02 |
| Stage1-vs-Stage2 |
5.078600E-01 |
| Stage1-vs-Stage3 |
4.315400E-01 |
| Stage1-vs-Stage4 |
7.692200E-01 |
| Stage2-vs-Stage3 |
2.927400E-01 |
| Stage2-vs-Stage4 |
5.362800E-01 |
| Stage3-vs-Stage4 |
8.211000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.87539999999087E-06 |
| Normal-vs-AfricanAmerican |
3.687900E-02 |
| Normal-vs-Asian |
9.794800E-01 |
| Caucasian-vs-AfricanAmerican |
9.440100E-02 |
| Caucasian-vs-Asian |
3.021000E-01 |
| AfricanAmerican-vs-Asian |
3.364600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.93889999999808E-06 |
| Normal-vs-Female |
4.071600E-02 |
| Male-vs-Female |
7.786000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.40600000000124E-05 |
| Normal-vs-Extreme_Weight |
3.28480000000297E-06 |
| Normal-vs-Obese |
1.415600E-02 |
| Normal-vs-Extreme_Obese |
5.478100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.483000E-01 |
| Normal_Weight-vs-Obese |
1.108580E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.189800E-01 |
| Extreme_Weight-vs-Obese |
8.814400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.476400E-01 |
| Obese-vs-Extreme_Obese |
8.344400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.024000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.380200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.60577999999134E-05 |
| Normal-vs-Age(81-100Yrs) |
1.738790E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.450800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.301780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.597900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.982300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.740560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.839000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.248100E-04 |
| Normal-VS-Type2 PRCC |
2.37380000001064E-06 |
| Normal-VS-KIRP CIMP |
9.332400E-01 |
| Normal-VS-Unclassified PRCC |
3.274100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.619900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.179700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.349400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.157840E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.032200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.365050E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.978100E-04 |
| Normal-vs-N1 |
6.675600E-03 |
| Normal-vs-N2 |
4.056300E-02 |
| N0-vs-N1 |
5.958200E-01 |
| N0-vs-N2 |
6.684600E-01 |
| N1-vs-N2 |
3.811400E-01 |
|
|
